Studies have shown that antitumor effect of BTZ on MCL cells is primarily exerted by increasing the proapoptotic protein Noxa; however, the accumulation of antiapoptotic protein Mcl-1 induced by inhibition of intracellular proteasome activity via BTZ weakens the antitumor effect of the drug 20–23. Here, MCL1 is linked to mantle cell lymphoma.